[Repeated amenorrhea after body weight loss. Efficacy of treatment of estrogen and gestagen depending on the body mass index].
The aim of the study was to evaluate end effect of different doses of estradiol and BMI changes by the time of therapy and BMI changes before therapy. We found that most important is to increase body mass to have regular cycles and there is no difference from statistical point of view to use different doses of estradiol (constant v. step down protocol). We used different progestogenic agents: medroksyprogesteron and dydrogesteron.
Hadaś
K
K
Katedry i Kliniki Endokrynologii Ginekologicznej A.M. w Poznaniu.
Warenik-Szymankiewicz
A
A
Halerz-Nowakowska
B
B
Maciejewska
M
M
D000568:Amenorrhea / Q000188:drug therapy* / Q000209:etiology*; D015992:Body Mass Index; D004305:Dose-Response Relationship, Drug; D004394:Dydrogesterone / Q000627:therapeutic use*; D004958:Estradiol / Q000627:therapeutic use*; D005260:Female; D006801:Humans; D008525:Medroxyprogesterone / Q000627:therapeutic use*; D045167:Progesterone Congeners / Q000627:therapeutic use*; D013997:Time Factors; D016896:Treatment Outcome; D015431:Weight Loss
D045167:Progesterone Congeners; D004958:Estradiol; D004394:Dydrogesterone; D008525:Medroxyprogesterone